<http://webisa.webdatacommons.org/214177219>	<http://www.w3.org/ns/prov#wasQuotedFrom>	<netplaces.com> .
<http://webisa.webdatacommons.org/prov/471781926>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/214177219> .
<http://webisa.webdatacommons.org/214177219>	<http://www.w3.org/ns/prov#value>	"Keep in mind that Tysabri is indicated for people with relapsing forms of MS, meaning that some people with progressive forms of MS who still experience relapses may be candidates for Tysabri." .
<http://webisa.webdatacommons.org/214177219>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/ns/prov#Entity> .